ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Circulating Wnt Pathway Factors Are Non-Invasive Biomarkers of Transplant Vascular Injury

M. Seifert,1 A. Malone,2 L. Boohaker,1 J. Gaut,2 S. Jain,2 D. Brennan,2,3 R. Mannon.1

1UAB School of Medicine, Birmingham
2Washington University, St. Louis
3Johns Hopkins University, Baltimore.

Meeting: 2018 American Transplant Congress

Abstract number: A34

Keywords: Alloantibodies, Endothelial activation, Kidney transplantation, Vascular disease

Session Information

Session Name: Poster Session A: Biomarkers, Immune Monitoring and Outcomes

Session Type: Poster Session

Date: Saturday, June 2, 2018

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall 4EF

Purpose: Transplant vascular injury (TVI) is a major cause of renal allograft failure and is resistant to treatment. Non-invasive pathogenic biomarkers of TVI would provide new diagnostic and treatment options. We hypothesized that circulating Wnt pathway factors, which are pathogenic in native renal disease, would also be novel biomarkers of TVI.

Methods: Cross-sectional study of 120 kidney recipients with biopsy-proven TVI (n=66; with 33 antibody-mediated rejection and 33 transplant glomerulopathy) or no major transplant abnormality (NOMOA, n=54). We measured Wnt pathway factors in biopsy-correlated serum/plasma samples by ELISA, including activin-A, fibroblast growth factor-23 (FGF23) and sclerostin (SOST). Optimal diagnostic cutoffs were determined using the Youden index. We compared mean levels between TVI and NOMOA by the Mann-Whitney-U test. We evaluated diagnostic performance by ROC analysis and logistic regression.

Results: TVI and NOMOA had similar clinical/demographic data except that TVI had lower estimated GFR (32 vs. 40 mL/min/1.73 m2, P=0.04). Mean serum Activin-A (530 ± 41 vs. 394 ± 27) and plasma FGF23 levels (427 ± 85 vs. 418 ± 113) were higher and serum SOST levels (137 ± 10 vs. 168 ± 11) were lower in TVI vs. NOMOA (all P<0.05). The best diagnostic index for TVI combined high FGF23 with low SOST levels (Table) and was robust to adjustment for eGFR [aOR (95% CI) = 7.5 (3.0, 19.0); P<0.0001].

Biomarker Performance Metrics
Optimal Cutoff Values for TVI ROC c-statistic Sensitivity Specificity PPV NPV Accuracy
eGFR < 42 mL/min/1.73 m2 0.629 76% 50% 64% 63% 64%
Activin-A > 306 pg/mL 0.577 78% 37% 58% 61% 59%
FGF23 > 77 RU/mL 0.642 95% 33% 61% 86% 66%
SOST < 140 pg/mL 0.632 62% 65% 66% 60% 63%
All 3 biomarkers 0.653 42% 89% 81% 58% 64%
High FGF23 + Low SOST 0.717 60% 83% 80% 65% 71%

Conclusions: High FGF23 and low SOST levels have better non-invasive diagnostic performance for TVI compared to eGFR. Once validated in an external cohort, circulating Wnt factors should be further explored as novel diagnostic and therapeutic targets.

CITATION INFORMATION: Seifert M., Malone A., Boohaker L., Gaut J., Jain S., Brennan D., Mannon R. Circulating Wnt Pathway Factors Are Non-Invasive Biomarkers of Transplant Vascular Injury Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Seifert M, Malone A, Boohaker L, Gaut J, Jain S, Brennan D, Mannon R. Circulating Wnt Pathway Factors Are Non-Invasive Biomarkers of Transplant Vascular Injury [abstract]. https://atcmeetingabstracts.com/abstract/circulating-wnt-pathway-factors-are-non-invasive-biomarkers-of-transplant-vascular-injury/. Accessed June 5, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences